| Identification | Back Directory | [Name]
10(9H)-Acridineacetic acid, 3-chloro-6-(1,1-dimethylethyl)-4-(methylthio)-9-oxo- | [CAS]
2332803-84-4 | [Synonyms]
SNX281
10(9H)-Acridineacetic acid, 3-chloro-6-(1,1-dimethylethyl)-4-(methylthio)-9-oxo- | [Molecular Formula]
C20H20ClNO3S | [MOL File]
2332803-84-4.mol | [Molecular Weight]
389.9 |
| Chemical Properties | Back Directory | [Boiling point ]
588.7±50.0 °C(Predicted) | [density ]
1.37±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
3.52±0.10(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Uses]
SNX281 is a systemically active STING agonist that binds to the STING protein, promotes signal transduction of the cGAS-STING pathway, and increases cellular responses to tumor cells. SNX281 can be used in the study of anti-tumor immunity[1]. | [References]
[1] Catherine SCHOLZ, et al. Biomarkers for sting agonists and methods of using the same. WO2023039363A1.2022-09-02 |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|